Skyrizi 600 mg concentrate for solution for infusion
*Company:
AbbVie LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 29 July 2024
File name
Skyrizi_SmPC_600mg_UC & 180mg OBI_July 24_clean.pdf
Reasons for updating
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 29 July 2024
File name
Skyrizi_PIL_600mg_UC & 180mg OBI_July 24_clean.pdf
Reasons for updating
- Change to Section 1 - what the product is
- Change to section 4 - possible side effects
- Change to date of revision
Updated on 22 January 2024
File name
Skyrizi_SmPC_600mg_Renewal & 90mg PFS_Jan 24.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 22 January 2024
File name
Skyrizi_PIL_600mg_Renewal & 90mg PFS_Jan 24.pdf
Reasons for updating
- New PIL for new product